1) Transcatheter portal vein embolization
经导管门静脉栓塞术
2) percutaneous transhepatic portal embolization
经皮经肝门静脉栓塞术
1.
Objective To explore the nursing care of patients after percutaneous transhepatic portal embolization(PTPE) in patients with advanced hilar cholangiocarcinoma.
目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
3) Portal vein embolization
门静脉栓塞术
1.
Portal vein embolization, a review;
门静脉栓塞术的理论基础
2.
Objective:Researching the effect of applying selective portal vein embolization(SPVE) in the primary hepatic carcinoma patients.
目的:研究选择性门静脉栓塞术(SPVE)在原发性肝癌治疗中的作用。
4) Transcatheter arterial embolization
经导管动脉栓塞术
1.
Transcatheter arterial embolization were carried out immediately after occurance of nosebleeding.
结论 经导管动脉栓塞术是治疗急性顽固性鼻出血的有效手段 ,其创伤小疗效肯定。
2.
Objective To evaluate the effect of transcatheter arterial embolization (TAE) for hepatic cellular carcinoma(HCC) by observing the blood flow changes in HCC after TAE with echo contrast agent (Levovist) enhanced colour Doppler flow imaging(CDFI).
目的 :应用经Levovist增强的彩色多普勒血流显像 (CDFI)观测肝细胞癌 (HCC)在经导管动脉栓塞术 (TAE)治疗后的血供变化 ,以评估TAE治疗HCC的效果。
5) transcatheter arterial chemoembolization
经导管动脉化疗栓塞术
1.
Clinical application of diffusion weighted MR imaging in follow-up of patients receiving transcatheter arterial chemoembolization for liver cancer;
磁共振扩散加权成像在肝癌经导管动脉化疗栓塞术后随访中的初步临床应用
2.
Purpose: To investigate the blood perfusion changes of hepatocellular carcinoma(HCC) before and after transcatheter arterial chemoembolization(TACE).
目的:探讨经导管动脉化疗栓塞术(TACE)治疗肝细胞癌(HCC)前后血流灌注变化。
6) Transcatheter arterial embolization
经导管动脉栓塞
1.
Therapeutic value of transcatheter arterial embolization for giant malignant pheochromocytoma
经导管动脉栓塞对巨大恶性嗜铬细胞瘤的治疗价值
2.
Conclusion Transcatheter arterial embolization with foam and/or coil is an appropriate and useful treatme.
目的 讨论经导管动脉栓塞治疗创伤性出血的方法和临床价值。
3.
Conclusion:Transcatheter arterial embolization with foam and/or coil is an appropriate and useful treatment in t.
目的:讨论经导管动脉栓塞治疗创伤性出血的方法和临床价值。
补充资料：门静脉插管化疗栓塞术
门静脉插管化疗栓塞术
the chemo?embolization of portal vein
由门静脉属支插管至或近门静脉的肿瘤分支，经该导管进行化学栓塞治疗的方法。门静脉参与肝癌血供及门静脉癌栓是肝癌肝内转移、复发及影响其预后的重要因素。故通过脐静脉、胃网膜静脉、回结肠静脉或经皮肝门静脉穿刺插管等方式，将导管送至或近其肿瘤分支处，如用带球囊导管则先膨胀球囊以防止栓塞剂反流，经导管注入抗癌药及栓塞剂；常用抗癌药有阿霉素、丝裂霉素、氟尿嘧啶、顺铂等；栓塞剂如碘油、明胶海绵粒、自凝血块、纤维蛋白等。该法常与肝动脉栓塞术合并使用，疗效较单一栓塞术好。肿瘤及门静脉癌栓的坏死率更高，但相应的肝组织损伤较大，须掌握好其适应证。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条